[
  {
    "date": "2023-12-30",
    "symbol": "ACHL",
    "period": "FY",
    "documenttype": "20-F",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "ACHL",
    "entityregistrantname": "Achilles Therapeutics plc",
    "entitycentralindexkey": 1830749,
    "currentfiscalyearenddate": "--12-31",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "entitycommonstocksharesoutstanding": 41082948,
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "true",
    "entityfilenumber": "001-40299",
    "entityincorporationstatecountrycode": "X0",
    "contactpersonnelname": "Daniel C.C. Hood",
    "entityaddressaddressline1": "245 Hammersmith Road",
    "entityaddresscityortown": "London",
    "entityaddresscountry": "GB",
    "entityaddresspostalzipcode": "W6 8PW",
    "cityareacode": 44,
    "localphonenumber": "(0)20 8154 4600",
    "contactpersonnelemailaddress": "legal@achillestx.com",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "documentregistrationstatement": "false",
    "documentaccountingstandard": "U.S. GAAP",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "security12btitle": "American Depositary Shares, each representing one ordinary share, nominal value of Â£0.001 per share",
    "securityexchangename": "NASDAQ",
    "notradingsymbolflag": "true",
    "auditorname": "KPMG, LLP",
    "auditorlocation": "Reading, United Kingdom",
    "auditorfirmid": 1118,
    "cashandcashequivalentsatcarryingvalue": 131539000,
    "prepaidexpenseandotherassetscurrent": 14094000,
    "assetscurrent": 145633000,
    "propertyplantandequipmentnet": 9171000,
    "operatingleaserightofuseasset": 4372000,
    "deferredincometaxassetsnet": 41000,
    "restrictedcash": 33000,
    "otherassetsnoncurrent": 2206000,
    "assetsnoncurrent": 15823000,
    "assets": 161456000,
    "accountspayablecurrent": 5629000,
    "accruedliabilitiesandotherliabilities": 7828000,
    "operatingleaseliabilitycurrent": 3539000,
    "liabilitiescurrent": 16996000,
    "operatingleaseliabilitynoncurrent": 1076000,
    "otherliabilitiesnoncurrent": 1015000,
    "liabilitiesnoncurrent": 2091000,
    "liabilities": 19087000,
    "commonstockvalue": 54000,
    "deferredcompensationarrangementwithindividualrecordedliability": 128000,
    "additionalpaidincapital": 415210000,
    "accumulatedothercomprehensiveincomelossnetoftax": -13071000,
    "retainedearningsaccumulateddeficit": -259952000,
    "stockholdersequity": 142369000,
    "liabilitiesandstockholdersequity": 161456000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 41082948,
    "commonstocksharesissued": 41082948,
    "commonstocksharesoutstanding": 41082948,
    "deferredsharesparorstatedvaluepershare": 92451.851,
    "deferredsharesauthorized": 1,
    "deferredsharesissued": 1,
    "deferredsharesoutstanding": 1,
    "researchanddevelopmentexpense": 58246000,
    "generalandadministrativeexpense": 17009000,
    "operatingexpenses": 75255000,
    "operatingincomeloss": -75255000,
    "othernonoperatingincomeexpense": 6081000,
    "nonoperatingincomeexpense": 6081000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -69174000,
    "incometaxexpensebenefit": 491000,
    "netincomeloss": -69665000,
    "othercomprehensiveincomeforeigncurrencytransactionandtranslationadjustmentnetoftaxportionattributabletoparent": 8624000,
    "comprehensiveincomenetoftax": -61041000,
    "earningspersharebasic": -1.74,
    "earningspersharediluted": -1.74,
    "weightedaveragenumberofsharesoutstandingbasic": 39973059,
    "weightedaveragenumberofdilutedsharesoutstanding": 39973059,
    "sharesoutstanding": 41082948,
    "stockissuedduringperiodsharesnewissues": 312606,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 6357000,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": 8624000,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 9000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 12210,
    "forfeitureofordinarysharesshares": -174595,
    "depreciationdepletionandamortization": 4713000,
    "gainlossonsaleofpropertyplantequipment": -2000,
    "gainlossonterminationoflease": 45000,
    "assetimpairmentcharges": 16000,
    "increasedecreaseinoperatingleaseliability": -231000,
    "foreigncurrencytransactiongainlossbeforetax": 5000,
    "sharebasedcompensation": 6357000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -10109000,
    "increasedecreaseinaccountspayable": 257000,
    "increasedecreaseinincometaxespayablenetofincometaxesreceivable": -326000,
    "increasedecreaseinaccruedliabilities": -801000,
    "increasedecreaseinothernoncurrentliabilities": 33000,
    "increasedecreaseindeferredincometaxes": -210000,
    "increasedecreaseinotheroperatingassets": -927000,
    "netcashprovidedbyusedinoperatingactivities": -48449000,
    "paymentstoacquirepropertyplantandequipment": 1100000,
    "netcashprovidedbyusedininvestingactivities": -1100000,
    "proceedsfromissuanceofcommonstock": 9000,
    "netcashprovidedbyusedinfinancingactivities": 9000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": 7741000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -41799000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 131572000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 2108000,
    "rightofuseassetsterminatedinexchangeforoperatingleaseliabilitiesnet": -1916000,
    "capitalexpendituresincurredbutnotyetpaid": 540000,
    "incometaxespaidnet": 626000,
    "numberofoperatingsegments": 1,
    "foreigncurrencytransactiongainlossrealized": -1000000,
    "operatingleaserequiredminimumbalanceinconnectionwithletterofcredit": 100000,
    "goodwillimpairmentloss": 100000,
    "newpercentageofqualifyingresearchanddevelopmentexpenditure": 0.2697,
    "researchanddevelopmenttaxcreditreceivable": 9400000,
    "grantsreceivable": 1000000,
    "caponresearchanddevelopmentclaimstomultipleofpayrolltaxesmaximumpayablecredit": 20000,
    "percentageofqualifyingresearchanddevelopmentexpenditureinrespectofconnectedparties": 0.15,
    "researchanddevelopmentreliefsundersmallormediumsizedenterprisesonperprojectbasismaximumaidlimited": 7500000,
    "propertyplantandequipmentusefullife": "P5Y",
    "propertyplantandequipmentdepreciationmethodextensibleenumeration": "http://fasb.org/us-gaap/2023#UsefulLifeTermOfLeaseMember",
    "cashandcashequivalentsfairvaluedisclosure": 76257000,
    "researchanddevelopmenttaxcreditreceivablecurrent": 9558000,
    "prepaidresearchanddevelopmentexpensescurrent": 1074000,
    "prepaidinsurance": 690000,
    "valueaddedtaxreceivablecurrent": 793000,
    "otherassetscurrent": 1979000,
    "propertyplantandequipmentgross": 9914000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 12915000,
    "depreciation": 4700000,
    "employeerelatedliabilitiescurrent": 2949000,
    "accruedexternalresearchanddevelopmentexpensescurrent": 3227000,
    "accruedprofessionalfeescurrent": 373000,
    "accruedpropertyandequipmentcurrent": 115000,
    "accruedfacilitycosts": 314000,
    "otheraccruedliabilitiescurrent": 850000,
    "accruedliabilitiescurrent": 7828000,
    "stockrepurchaseprogramnumberofsharesauthorizedtoberepurchased": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesissuedinperiod": 5834006,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 1141189,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 877065,
    "allocatedsharebasedcompensationexpense": 300000,
    "employeestockpurchaseprogramnumberofsharesreservedandavailabletogrant": 231972,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 174595,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 2600000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 0.81,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 4800000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 838845,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 383126,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 595202,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 243882,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 3.92,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 0.95,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 6.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 4.79,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 5057099,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2453312,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1388148,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 3668951,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 4.09,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1.15,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 4.13,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 7.36,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 2.86,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y3M7D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y2M8D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionunvestedweightedaverageremainingcontractualterm": "P8Y8M4D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 232000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 37000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsunvestedintrinsicvalue": 195000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y7D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsweightedaveragevolatilityrate": 0.7281,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0353,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprices": 1.19,
    "leaserenewalexpirationdate": "2025-05-31",
    "lesseeoperatingleaseliabilitypaymentsdue": 4816000,
    "collaborationagreementcancellationpenaltyamount": 100000,
    "amendmentandcollaborationagreementterms": "On February 22, 2024, the Company entered into an amendment to the manufacturing services collaboration agreement which extended the term through March 31, 2025.",
    "letterofcreditexpirationdate": "2024-09-30",
    "operatingleaseliability": 4615000,
    "operatingleasecost": 4655000,
    "variableleasecost": 5291000,
    "shorttermleasecost": 379000,
    "leasecost": 10325000,
    "operatingleasepayments": 4537000,
    "operatingleaseweightedaverageremainingleaseterm1": "P1Y3M18D",
    "operatingleaseweightedaveragediscountratepercent": 0.0661,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 3717000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 1099000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 201000,
    "aggregatemilestonepayments": 6500000,
    "contributionperiodofroyaltyproducts": "P10Y",
    "patentperiodofroyaltyproducts": "P5Y",
    "businessacquisitioncostofacquiredentitytransactioncosts": 25000000,
    "expensesrelatedtolicenseagreement": 100000,
    "operatinglosscarryforwards": 121700000,
    "effectiveincometaxratereconciliationtaxsettlements": 0.5,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.235,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -69329000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 155000,
    "currentforeigntaxexpensebenefit": 281000,
    "currentincometaxexpensebenefit": 281000,
    "deferredforeignincometaxexpensebenefit": 210000,
    "deferredincometaxexpensebenefit": 210000,
    "effectiveincometaxratereconciliationotheradjustments": -0.0995,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": -0.11,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.0339,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": 0.0013,
    "effectiveincometaxratecontinuingoperations": -0.0071,
    "deferredtaxassetsoperatinglosscarryforwards": 30435000,
    "deferredtaxassetspropertyplantandequipment": 606000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 6488000,
    "deferredtaxassetsother": 112000,
    "deferredtaxassetsgross": 37641000,
    "deferredtaxassetsvaluationallowance": 37600000,
    "deferredtaxassetsnet": 41000,
    "valuationallowancedeferredtaxassetchangeinamount": 2252000,
    "deferredtaxassetexchangedifference": 1774000,
    "deferredtaxassetschangeintaxrate": 94000,
    "netincomelossavailabletocommonstockholdersbasic": -69665000,
    "netincomelossavailabletocommonstockholdersdiluted": -69665000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 838845,
    "purchaseobligation": 3500000,
    "assetretirementobligation": 1015000,
    "assetretirementobligationaccretionexpense": 82000,
    "definedcontributionplanemployerdiscretionarycontributionamount": 2300000
  },
  {
    "date": "2022-12-31",
    "symbol": "ACHL",
    "period": "FY",
    "documenttype": "20-F",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "ACHL",
    "entityregistrantname": "Achilles Therapeutics plc",
    "entitycentralindexkey": 1830749,
    "currentfiscalyearenddate": "--12-31",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "entitycommonstocksharesoutstanding": "null",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "true",
    "entityfilenumber": "001-40299",
    "entityincorporationstatecountrycode": "England and Wales",
    "contactpersonnelname": "Daniel C.C. Hood",
    "entityaddressaddressline1": "245 Hammersmith Road",
    "entityaddresscityortown": "London",
    "entityaddresscountry": "United Kingdom",
    "entityaddresspostalzipcode": "W6 8PW",
    "cityareacode": 44,
    "localphonenumber": "(0)20 8154 4600",
    "contactpersonnelemailaddress": "legal@achillestx.com",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "documentregistrationstatement": "false",
    "documentaccountingstandard": "U.S. GAAP",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "security12btitle": "Ordinary shares, nominal value Â£0.001 per share",
    "securityexchangename": "Nasdaq Global Select Market",
    "notradingsymbolflag": "true",
    "auditorname": "KPMG, LLP",
    "auditorlocation": "Reading, United Kingdom",
    "auditorfirmid": 1118,
    "cashandcashequivalentsatcarryingvalue": 173338000,
    "prepaidexpenseandotherassetscurrent": 23242000,
    "assetscurrent": 196580000,
    "propertyplantandequipmentnet": 12399000,
    "operatingleaserightofuseasset": 8081000,
    "deferredincometaxassetsnet": 251000,
    "restrictedcash": 33000,
    "otherassetsnoncurrent": 3014000,
    "assetsnoncurrent": 23778000,
    "assets": 220358000,
    "accountspayablecurrent": 5187000,
    "taxespayablecurrent": 326000,
    "accruedliabilitiesandotherliabilities": 8292000,
    "operatingleaseliabilitycurrent": 4188000,
    "liabilitiescurrent": 17993000,
    "operatingleaseliabilitynoncurrent": 4388000,
    "otherliabilitiesnoncurrent": 933000,
    "liabilitiesnoncurrent": 5321000,
    "liabilities": 23314000,
    "commonstockvalue": 54000,
    "deferredcompensationarrangementwithindividualrecordedliability": 128000,
    "additionalpaidincapital": 408844000,
    "accumulatedothercomprehensiveincomelossnetoftax": -21695000,
    "retainedearningsaccumulateddeficit": -190287000,
    "stockholdersequity": -190287000,
    "liabilitiesandstockholdersequity": 220358000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "deferredsharesparorstatedvaluepershare": 92451.851,
    "deferredsharesauthorized": 1,
    "deferredsharesissued": 1,
    "deferredsharesoutstanding": 1,
    "researchanddevelopmentexpense": 57263000,
    "generalandadministrativeexpense": 21120000,
    "operatingexpenses": 78383000,
    "operatingincomeloss": -78383000,
    "othernonoperatingincomeexpense": 7318000,
    "nonoperatingincomeexpense": 7318000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -71065000,
    "incometaxexpensebenefit": 111000,
    "netincomeloss": -71176000,
    "othercomprehensiveincomeforeigncurrencytransactionandtranslationadjustmentnetoftaxportionattributabletoparent": -28331000,
    "comprehensiveincomenetoftax": -99507000,
    "earningspersharebasic": -1.82,
    "earningspersharediluted": -1.82,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "sharesoutstanding": 1,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 1000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 319990,
    "forfeitureofordinarysharesshares": -6036,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 334781,
    "stockrepurchasedduringperiodshares": 1,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 7022000,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": -28331000,
    "depreciationdepletionandamortization": 3690000,
    "gainlossonsaleofpropertyplantequipment": 10000,
    "assetimpairmentcharges": 6700000,
    "increasedecreaseinoperatingleaseliability": -601000,
    "foreigncurrencytransactionlossbeforetax": 50000,
    "sharebasedcompensation": 7022000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 6845000,
    "increasedecreaseinaccountspayable": 1907000,
    "increasedecreaseinincometaxespayablenetofincometaxesreceivable": 326000,
    "increasedecreaseinaccruedliabilities": -1114000,
    "increasedecreaseinothernoncurrentliabilities": 321000,
    "increasedecreaseindeferredincometaxes": 225000,
    "increasedecreaseinotheroperatingassets": 326000,
    "netcashprovidedbyusedinoperatingactivities": -59535000,
    "paymentstoacquirepropertyplantandequipment": 7512000,
    "netcashprovidedbyusedininvestingactivities": -7512000,
    "proceedsfromissuanceofcommonstock": 1000,
    "netcashprovidedbyusedinfinancingactivities": 1000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": -25935000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -92981000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 173371000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 2111000,
    "capitalexpendituresincurredbutnotyetpaid": 649000,
    "stockholdersequityreversestocksplit": "one-for-0.1792",
    "numberofoperatingsegments": 1,
    "foreigncurrencytransactiongainlossrealized": 3800000,
    "operatingleaserequiredminimumbalanceinconnectionwithletterofcredit": 100000,
    "goodwillimpairmentloss": 500000,
    "percentageofqualifyingresearchanddevelopmentexpenditure": 0.18600000000000003,
    "percentageofsubcontractedqualifyingresearchanddevelopmentexpenditure": 0.21670000000000003,
    "researchanddevelopmenttaxcreditreceivable": 15600000,
    "grantsreceivable": 400000,
    "propertyplantandequipmentusefullife": 3,
    "propertyplantandequipmentdepreciationmethods": "Shorter of useful life or remaining lease term",
    "cashandcashequivalentsfairvaluedisclosure": 51901000,
    "researchanddevelopmenttaxcreditreceivablecurrent": 15232000,
    "prepaidresearchanddevelopmentexpensescurrent": 3473000,
    "prepaidinsurance": 1151000,
    "valueaddedtaxreceivablecurrent": 771000,
    "otherassetscurrent": 2615000,
    "propertyplantandequipmentgross": 20253000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 7854000,
    "depreciation": 3700000,
    "employeerelatedliabilitiescurrent": 2972000,
    "accruedexternalresearchanddevelopmentexpensescurrent": 2188000,
    "accruedprofessionalfeescurrent": 795000,
    "accruedpropertyandequipmentcurrent": 217000,
    "accruedfacilitycosts": 910000,
    "otheraccruedliabilitiescurrent": 1210000,
    "accruedliabilitiescurrent": 8292000,
    "stockrepurchaseprogramnumberofsharesauthorizedtoberepurchased": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesissuedinperiod": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 467738,
    "allocatedsharebasedcompensationexpense": 7022000,
    "percentageofsharesforfeitedandavailableforfutureissuanceifminimumserviceconditionsarenotfulfilled": 1,
    "employeestockpurchaseprogramnumberofsharesreservedandavailabletogrant": 147748,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four-year",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 6036,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 6100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.02,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 5500000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 356566,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 915817,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 49004,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 4.89,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.86,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 5.29,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 3.53,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 581514,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 6.18,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 10.88,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 5.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 8.51,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 7.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionunvestedweightedaverageremainingcontractualterm": 8.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 150000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsunvestedintrinsicvalue": 150000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsweightedaveragevolatilityrate": 0.6973999999999999,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.02,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 3.06,
    "numberofoperatinglease": 10,
    "lesseeoperatingleaseliabilitypaymentsdue": 9088000,
    "letterofcreditexpirationdate": "September 30, 2023",
    "operatingleasecost": 4512000,
    "variableleasecost": 3921000,
    "shorttermleasecost": 363000,
    "leasecost": 8796000,
    "operatingleasepayments": 4859000,
    "operatingleaseweightedaverageremainingleaseterm1": 2.3,
    "operatingleaseweightedaveragediscountratepercent": 0.0513,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 4517000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 3331000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 1240000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 512000,
    "operatingleaseliability": 8576000,
    "aggregatemilestonepayments": 800000,
    "contributionperiodofroyaltyproducts": "ten years",
    "patentperiodofroyaltyproducts": "five years",
    "businessacquisitioncostofacquiredentitytransactioncosts": 25000000,
    "expensesrelatedtolicenseagreement": 100000,
    "operatinglosscarryforwards": 140500000,
    "effectiveincometaxratereconciliationtaxsettlements": 0.5,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.19,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -71405000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 340000,
    "currentforeigntaxexpensebenefit": 337000,
    "currentincometaxexpensebenefit": 337000,
    "deferredforeignincometaxexpensebenefit": -226000,
    "deferredincometaxexpensebenefit": -226000,
    "effectiveincometaxratereconciliationotheradjustments": 0.0687,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": -0.083,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.23579999999999998,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": 0.056600000000000004,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": 0.0019,
    "effectiveincometaxratecontinuingoperations": -0.0016,
    "deferredtaxassetsoperatinglosscarryforwards": 35121000,
    "deferredtaxassetspropertyplantandequipment": 7989000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 4456000,
    "deferredtaxassetsother": 2143000,
    "deferredtaxassetsgross": 33731000,
    "deferredtaxassetsvaluationallowance": 33480000,
    "deferredtaxassetsnet": 251000,
    "valuationallowancedeferredtaxassetchangeinamount": 12731000,
    "deferredtaxassetexchangedifference": -2332000,
    "deferredtaxassetschangeintaxrate": 4019000,
    "netincomelossavailabletocommonstockholdersbasicanddiluted": -71176000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "purchaseobligation": 3800000,
    "assetretirementobligation": 933000,
    "assetretirementobligationliabilitiesincurred": 168000,
    "assetretirementobligationaccretionexpense": 75000,
    "definedcontributionplanemployerdiscretionarycontributionamount": 100000
  },
  {
    "date": "2021-12-31",
    "symbol": "ACHL",
    "period": "FY",
    "documenttype": "20-F",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "ACHL",
    "entityregistrantname": "Achilles Therapeutics plc",
    "entitycentralindexkey": 1830749,
    "currentfiscalyearenddate": "--12-31",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "entitycommonstocksharesoutstanding": "null",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "true",
    "entityfilenumber": "001-40299",
    "entityincorporationstatecountrycode": "England and Wales",
    "contactpersonnelname": "Daniel C.C. Hood",
    "entityaddressaddressline1": "245 Hammersmith Road",
    "entityaddresscityortown": "London",
    "entityaddresscountry": "United Kingdom",
    "entityaddresspostalzipcode": "W6 8PW",
    "cityareacode": 44,
    "localphonenumber": "(0)20 8154 4600",
    "contactpersonnelemailaddress": "legal@achillestx.com",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "documentregistrationstatement": "false",
    "documentaccountingstandard": "U.S. GAAP",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "security12btitle": "Ordinary shares, nominal value Â£0.001 per share",
    "securityexchangename": "Nasdaq Global Select Market",
    "notradingsymbolflag": "true",
    "auditorname": "KPMG, LLC",
    "auditorlocation": "Reading, United Kingdom",
    "auditorfirmid": 1118,
    "cashandcashequivalentsatcarryingvalue": 266319000,
    "prepaidexpenseandotherassetscurrent": 18430000,
    "assetscurrent": 284749000,
    "propertyplantandequipmentnet": 17743000,
    "operatingleaserightofuseasset": 11048000,
    "deferredincometaxassetsnet": 26000,
    "restrictedcash": 33000,
    "otherassetsnoncurrent": 3507000,
    "assetsnoncurrent": 32357000,
    "assets": 317106000,
    "accountspayablecurrent": 3722000,
    "accruedliabilitiesandotherliabilities": 10906000,
    "operatingleaseliabilitycurrent": 4482000,
    "liabilitiescurrent": 19110000,
    "operatingleaseliabilitynoncurrent": 7777000,
    "otherliabilitiesnoncurrent": 691000,
    "liabilitiesnoncurrent": 8468000,
    "liabilities": 27578000,
    "commonstockvalue": 54000,
    "deferredcompensationarrangementwithindividualrecordedliability": 128000,
    "additionalpaidincapital": 401821000,
    "accumulatedothercomprehensiveincomelossnetoftax": 6636000,
    "retainedearningsaccumulateddeficit": -119111000,
    "stockholdersequity": -119111000,
    "liabilitiesandstockholdersequity": 317106000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "deferredsharesparorstatedvaluepershare": 92451.851,
    "deferredsharesauthorized": 1,
    "deferredsharesissued": 1,
    "deferredsharesoutstanding": 1,
    "preferredstockparorstatedvaluepershare": 0.001,
    "researchanddevelopmentexpense": 42224000,
    "generalandadministrativeexpense": 21971000,
    "operatingexpenses": 64195000,
    "operatingincomeloss": -64195000,
    "othernonoperatingincomeexpense": 3133000,
    "nonoperatingincomeexpense": 3133000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -61062000,
    "incometaxexpensebenefit": 37000,
    "netincomeloss": -61099000,
    "othercomprehensiveincomeforeigncurrencytransactionandtranslationadjustmentnetoftaxportionattributabletoparent": -5686000,
    "comprehensiveincomenetoftax": -66785000,
    "earningspersharebasicanddiluted": -2.13,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "sharesoutstanding": 1,
    "stockissuedduringperiodvaluenewissues": 160624000,
    "stockissuedduringperiodsharesnewissues": "null",
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 78537,
    "effectofcorporatereorganizationincludingconversionofpreferredsharestoordinaryshares": -28000,
    "temporaryequityeliminationaspartofreorganizationshares": "null",
    "temporaryequityeliminationaspartofreorganization": 32000,
    "effectofcorporatereorganizationincludingconversionofpreferredsharetoordinaryshareshares": -109057,
    "stockrepurchasedduringperiodshares": 1,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 6317000,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": -5686000,
    "depreciationdepletionandamortization": 3288000,
    "gainlossonsaleofpropertyplantequipment": -156000,
    "increasedecreaseinoperatingleaseliability": -18000,
    "foreigncurrencytransactionlossbeforetax": 3000,
    "sharebasedcompensation": 6317000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 9771000,
    "increasedecreaseinaccountspayable": -2572000,
    "increasedecreaseinincometaxespayablenetofincometaxesreceivable": -7000,
    "increasedecreaseinaccruedliabilities": 4937000,
    "increasedecreaseinothernoncurrentliabilities": 47000,
    "increasedecreaseindeferredincometaxes": 22000,
    "increasedecreaseinotheroperatingassets": 543000,
    "netcashprovidedbyusedinoperatingactivities": -59284000,
    "paymentstoacquirepropertyplantandequipment": 7634000,
    "netcashprovidedbyusedininvestingactivities": -7634000,
    "proceedsfromissuanceinitialpublicoffering": 75000000,
    "netcashprovidedbyusedinfinancingactivities": 160755000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": -5334000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 88503000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 266352000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 314000,
    "capitalexpendituresincurredbutnotyetpaid": 726000,
    "stockholdersequityreversestocksplit": "one-for-0.1792",
    "numberofoperatingsegments": 1,
    "foreigncurrencytransactiongainlossrealized": 2500000,
    "operatingleaserequiredminimumbalanceinconnectionwithletterofcredit": 100000,
    "goodwillimpairmentloss": 100000,
    "percentageofqualifyingresearchanddevelopmentexpenditure": 0.3335,
    "percentageofsubcontractedqualifyingresearchanddevelopmentexpenditure": 0.21670000000000003,
    "propertyplantandequipmentusefullife": 3,
    "propertyplantandequipmentdepreciationmethods": "Shorter of useful life or remaining lease term",
    "cashandcashequivalentsfairvaluedisclosure": 40224000,
    "researchanddevelopmenttaxcreditreceivablecurrent": 10523000,
    "prepaidresearchanddevelopmentexpensescurrent": 3608000,
    "prepaidinsurance": 1525000,
    "valueaddedtaxreceivablecurrent": 650000,
    "otherassetscurrent": 2124000,
    "propertyplantandequipmentgross": 22195000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 4452000,
    "depreciation": 3300000,
    "employeerelatedliabilitiescurrent": 2649000,
    "accruedexternalresearchanddevelopmentexpensescurrent": 2985000,
    "accruedfacilitycosts": 2629000,
    "accruedpropertyandequipmentcurrent": 712000,
    "accruedprofessionalfeescurrent": 663000,
    "otheraccruedliabilitiescurrent": 1268000,
    "accruedliabilitiescurrent": 10906000,
    "numberofvotepershare": 1,
    "stockrepurchaseprogramnumberofsharesauthorizedtoberepurchased": 1,
    "convertiblepreferredstocktermsofconversion": "All Convertible Preferred Shares will automatically convert into an equivalent number of B ordinary shares upon either: (i)Â the notice of 60% of Convertible Preferred Shareholders that such conversion shall occur; or (ii)Â immediately upon an initial public offering in which the per share net public offering is at least 1.15 times Â£2.1589 (subject to appropriate adjustment in the event of any share dividend, share split, combination or other similar recapitalization)",
    "convertiblepreferredsharesconversionratio": 1,
    "percentageofconvertiblepreferredshareholders": 0.6,
    "initialpublicofferingnetofferingpershare": 2.1589,
    "sharesissuedpricepershare": 1.916,
    "percentageofpreferredshareswaived": 0.8,
    "preferredstockvotingrights": "The Convertible Preferred Shares carried the right to one vote per Convertible Preferred Share held.",
    "percentageofoutstandingconvertiblepreferredshares": 1,
    "amountofdeferredsharespaidafterconvertiblepreferredshares": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardincreaseofreservedsharespercentofordinarysharesoutstanding": 0.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesissuedinperiod": 467738,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 467738,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasespaymentawardremainingvestingperiod": "three years",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 11300000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 3.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.42,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 5400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 916172,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 18262,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 6.43,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 5.61,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 6.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 47515,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 102424,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 8.95,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 13.83,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 12.98,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 6.99,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 9.11,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P4Y10M2D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P4Y4M13D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionunvestedweightedaverageremainingcontractualterm": "P8Y11M1D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 10000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsunvestedintrinsicvalue": 10000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6.02,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsweightedaveragevolatilityrate": 0.7215,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.010700000000000001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 9.53,
    "allocatedsharebasedcompensationexpense": 6317000,
    "numberofoperatinglease": 7,
    "numberofleasesmetshorttermexception": 3,
    "lesseeoperatingleaseliabilitypaymentsdue": 13157000,
    "operatingleasecost": 4718000,
    "variableleasecost": 5022000,
    "shorttermleasecost": 65000,
    "leasecost": 9805000,
    "operatingleasepayments": 4736000,
    "operatingleaseweightedaverageremainingleaseterm1": 3.1,
    "operatingleaseweightedaveragediscountratepercent": 0.048600000000000004,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 4974000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 4322000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 3046000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 815000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 898000,
    "operatingleaseliability": 12259000,
    "aggregatemilestonepayments": 6500000,
    "contributionperiodofroyaltyproducts": "ten years",
    "patentperiodofroyaltyproducts": "ten years",
    "businessacquisitioncostofacquiredentitytransactioncosts": 25000000,
    "expensesrelatedtolicenseagreement": 100000,
    "rateofaggregatemilestonepayments": 1.132,
    "commercialmilestonepayments": 26000000,
    "rateofcommercialmilestonepayments": 1.132,
    "licenseexpense": 700000,
    "averagerateoflicenseexpense": 1.183,
    "operatinglosscarryforwards": 71000000,
    "effectiveincometaxratereconciliationtaxsettlements": 0.5,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.19,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -61182000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 120000,
    "currentforeigntaxexpensebenefit": 59000,
    "currentincometaxexpensebenefit": 59000,
    "deferredforeignincometaxexpensebenefit": -22000,
    "deferredincometaxexpensebenefit": -22000,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": -0.0667,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.20120000000000002,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": 0.0764,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": -0.0013000000000000002,
    "effectiveincometaxratecontinuingoperations": -0.0028000000000000004,
    "deferredtaxassetsoperatinglosscarryforwards": 17742000,
    "deferredtaxassetspropertyplantandequipment": 1311000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 2328000,
    "deferredtaxassetsother": 329000,
    "deferredtaxassetsgross": 19088000,
    "deferredtaxassetsvaluationallowance": 19062000,
    "deferredtaxassetsnet": 26000,
    "valuationallowancedeferredtaxassetchangeinamount": 7624000,
    "deferredtaxassetexchangedifference": -313000,
    "deferredtaxassetschangeintaxrate": 4663000,
    "netincomelossavailabletocommonstockholdersbasicanddiluted": -61099000,
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "purchaseobligation": 7400000,
    "assetretirementobligation": 690000,
    "assetretirementobligationaccretionexpense": 38000,
    "definedcontributionplanemployerdiscretionarycontributionamount": 100000
  }
]